Chem. J. Chinese Universities

• 研究论文 • Previous Articles     Next Articles

Preparation and in vitro Experimental Study of Methotrexate-Lactosyl-Chitosan Conjugate

WANG Yin-Song1*, HAN Yue-Lian2, LI Ying-Xia3, WANG Yu-Mei1, LI Rong-Shan1   

    1. Pharmacy College, Tianjin Medical University, Tianjin 300070, China;
    2. Qingdao Hair Pharmaceutical Co. Ltd., Qingdao 266103, China;
    3. Institute of Marine Drug and Food, Ocean University of China, Qingdao 266003, China
  • Received:2006-10-16 Revised:1900-01-01 Online:2007-06-10 Published:2007-06-10
  • Contact: WANG Yin-Song

Abstract: N-Lactosyl-chitosan(LCH) with different degrees of substitution(DS) of lactosyl group was synthesized and characterized with Fourier transform infrared(FTIR) and proton nuclear magnetic resonance(1H NMR). The result of radioactive experiment in vitro shows that LCH was a specific ligand for asialoglycoprotein receptor(ASGPR) when the DS of lactosyl group ranged from 15.5% to 38.9%, which indicates LCH could be used as a novel kind of hepatic targeting carrier. Methotrexate-lactosyl-chitosan(MTX-LCH) was prepared via the following synthetic route: MTX was firstly coupled with chitosan, and then reacted with lactobionic acid to produce MTX-LCH. The DS of MTX moiety of MTX-LCH was determined via ultraviolet(UV) spectroscopy to be 5.6%, and the DS of lactosyl group to be 33.8%. MTX-LCH was water-soluble in the pH range of 1—14. The dynamic dialysis study shows that MTX-LCH was stable, and the release of MTX was very slow. These results provided a reference for the further study of liver-targeting polymeric prodrugs.

Key words: N-Lactosyl chitosan, Methotrexate, Asialoglycoprotein receptor, Liver-targeting, Polymeric prodrug

CLC Number: 

TrendMD: